Overview

Elastography Imaging Market is poised to value over CAGR of over 11% during the forecast period of 2022 to 2028.

Elastography imaging is gaining popularity and replacing biopsy as it has additional advantages. It is a complete noninvasive procedure and is therefore preferred over other procedures. Elastography imaging is employed in the diagnosis of numerous chronic cancers. The services are primarily used to analyze liver disease as well. Elastography imaging find great applications in various medical practices and thus face high demand and is foreseen to grow at a healthy CAGR during the forecast period. A particular type of elastography imaging is used for musculoskeletal imaging to determine mechanical properties and state of muscle and tendon. Owing to these factors, the global market faces high demand and is expected to soar in the near future.

The growing number of fatal chronic diseases and their incidence due to an unhealthy lifestyle and habits lead to an increase in demand for healthcare facilities. Increasing incidences of various fatal ailments is expected to favor the demand for elastography imaging devices.The growing adoption of minimally invasive procedures favors the growth of the market. Furthermore, a rise in consumer awareness positively affects the global market.

Elastography imaging is a widely performed procedure serving as an inexpensive, portable and reliable diagnostic accuracy alternative to traditional means.

North America is the most significant region for the market due to the growing adoption of superior imaging techniques and the immediate commercialization of devices in the U.S. market. Western Europe is expected to contribute a major share in the market. Factors such as growing research projects and rising adoption of ultrasound screening favor the growth of the Europe market.

Companies are focusing on the launch of new elastography imaging product, which expected to favor the growth of the market. Manufacturers are focusing on clinical trials and FDA approvals for market expansion. In 2017, FDA approved Phillips ElastQ Imaging capability (shear wave elastography) for imaging of tissue.

Major market firms in global market are:

Samsung Medison, GE healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hitachi Ltd., Mindray Medical International Limited, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Landwind Medical, Esaote Spa, SonoScape Medical Corp, SuperSonic Imagine and others.

Market Segmentation:

By Modality

Ultrasound
Magnetic Resonance

By Application

Radiology/General Imaging
Cardiology
Obstetrics/Gynecology
Urology
Vascular
Orthopedic & Musculoskeletal Applications
Other Applications

By End-User

Hospitals, Surgical Centers, & Diagnostic Centers
Ambulatory Surgical Centers
Other End Users

By Region

Europe
North America
Aisa Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data points affecting market growth

Objectives of the Study:

To provide an exhaustive analysis on the global market by modality, by application, by end-user, and by region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com